Aβ Classification Predicts Outcomes in Pediatric Ketosis- Prone Diabetes
Needs Statement
To ensure accurate and effective patient care, healthcare providers in endocrinology require enhanced knowledge of core endocrine conditions, including the latest diagnostic and therapeutic approaches. There is a need to strengthen competence in applying evidence-based medicine and clinical guidelines, while also promoting high-value care and performance excellence across all disciplines within endocrinology. Additionally, providers must understand the scientific rigor behind guideline development and explore novel models of multidisciplinary care that foster collaboration and improve patient outcomes. This series aims to support these needs by offering regular updates on advances in basic science and clinical research, emerging treatment modalities, and evolving management strategies for endocrine disorders. By inviting expert speakers, the series delivers authoritative insights and practical strategies for improving clinical outcomes.
Target Audience
Physicians, medical students, fellows, residents, nurses, and other health professionals.
Learning Objectives
- Define the heterogeneity of pediatric ketosis-prone diabetes (KPD) using the Aβ classification framework based on islet autoimmunity and β-cell functional reserve.
- Compare long-term metabolic and clinical outcomes across Aβ-defined pediatric KPD subgroups and identify early predictors of these outcomes.
- Apply Aβ classification to individualized clinical management in youth with KPD.
Available Credit
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Participation
Price
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact [email protected].

Facebook
X
LinkedIn
Forward